Third Tysabri adverse case hits drug class

Nat Rev Drug Discov. 2005 May;4(5):357-8. doi: 10.1038/nrd1743.
No abstract available

Publication types

  • News

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / classification
  • Antibodies, Monoclonal, Humanized
  • Humans
  • Leukoencephalopathy, Progressive Multifocal / chemically induced*
  • Leukoencephalopathy, Progressive Multifocal / immunology
  • Multiple Sclerosis / drug therapy
  • Multiple Sclerosis / immunology
  • Natalizumab
  • Nervous System Diseases / chemically induced
  • Nervous System Diseases / immunology

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Natalizumab